NuVision Pharmacy Recalls Methylcobalamin Injection Due to Sterility Concerns
NuVision Pharmacy is recalling 32 vials of Methylcobalamin Injection due to lack of assurance of sterility and reports of adverse events.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves reports of adverse events after injection, which aligns with the 'Severe' criteria for significant injury reports or Class II recalls with adverse outcomes.
Plain-English summary
NuVision Pharmacy, Inc. is recalling 32 vials of Methylcobalamin (Buffered) Injection, 1 mg/mL, 30 mL vial, Stock# 11126. The product was compounded by NuVision Pharmacy in Dallas, TX, and distributed to Florida, Missouri, Utah, and Washington.
The recall was initiated due to a lack of assurance of sterility and reports of adverse events following injection. The affected lot number is N01232013@4, with a 'Do Not Use Beyond' date of January 1, 2014.
Consumers and healthcare providers should stop using the product immediately and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- Methylcobalamin (Buffered) Injection,1 mg/mL, 30 mL vial, Stock# 11126, Preservative Free, Compounded by NuVision Pharmacy, Inc., Dallas, TX 75244
- Manufacturer
- NuVision Pharmacy, Inc.
- Hazard
- Affected units
- 32
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot Number N01232013@4
- Do Not Use Beyond Date of January 1
- 2014
Distribution
Related recalls
Same manufacturer · NuVision Pharmacy, Inc.
See all →- CriticalNuVision Pharmacy Recalls Sermorelin/GHRP-6 Vials Due to Sterility Concerns
FDA (Drugs) · 2014-02-05
- SevereNuVision Pharmacy Recalls HCG Vials Due to Sterility Assurance Concerns
FDA (Drugs) · 2014-02-05
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29